Sage Therapeutics CEO on why its moving to treat depression next

In this video

Share

Sage Therapeutics CEO on why its moving to treat depression next

Sage CEO Jeff Jonas joins CNBC's "Power Lunch" to discuss its earnings report and the outlook for new drugs and treatments.
03:53
Wed, Jul 24 20193:59 PM EDT